PATENT CLAIM ANALYSIS

Application Number: 15977276
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "289000"]

Abstract:
This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and bupropion, hydroxybupropion, erythrohydroxybupropion, threohydroxybupropion, or a metabolite or prodrug of any of these compounds are also disclosed

Claim (Index 13):
The method of  claim 1 , wherein the C max  of dextromethorphan on the eighth day is at least about 30 times the C max  of dextromethorphan that would result from administering the same amount of the dextromethorphan without the bupropion for eight consecutive days.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15206057', '15688660', '15691532', '15933075', '15182253']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8797223145204243
- 35 USC 102 Novelty (BERT): 0.696716203290197
- Combined Prediction Score: 0.8614217033974017
- Mean Citation Score: 730.4778859999999
- Max Citation Score: 733.5992
- Similarity Product: 709.1857946926117

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test